An update on current understanding of the epidemiology and management of the re-emerging endemic Lassa fever outbreaks

. 2023 Mar 01 ; 109 (3) : 584-586. [epub] 20230301

Jazyk angličtina Země Spojené státy americké Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid37093095
Odkazy

PubMed 37093095
PubMed Central PMC10389424
DOI 10.1097/js9.0000000000000178
PII: 01279778-202303000-00074
Knihovny.cz E-zdroje

Erratum v

PubMed

Zobrazit více v PubMed

Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg 1970;19:680–691. PubMed

Olayemi A, Cadar D, Magassouba N, et al. . New hosts of the Lassa virus. Sci Rep 2016;6:25280. PubMed PMC

WHO. Lassa fever. 2019. Accessed 18 March 2019. https://www.who.int/emergencies/diseases/Lassa-fever/en/

Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ 2003;327:1271–1275; Erratum in:BMJ. 2004;328(7431):96. PubMed PMC

World Health Organization. WHO R&D blueprint. “Efficacy trials of Lassa therapeutics: endpoints, trial design, site selection” WHO workshop—final report. 2018.

Garry RF. Lassa fever – the road ahead. Nat Rev Microbiol 2023;21:87–96. PubMed PMC

Ilori EA, Furuse Y, Ipadeola OB, et al. . Nigeria Lassa Fever National Response Team. Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1-May 6, 2018. Emerg Infect Dis 2019;25:1066–1074. PubMed PMC

Balogun OO, Akande OW, Hamer DH. Lassa fever: an evolving emergency in West Africa. Am J Trop Med Hyg 2020;104:466–473. PubMed PMC

Massawe AW, Makundi RH, Zhang Z, et al. . Effect of synthetic hormones on reproduction in Mastomys natalensis . J Pest Sci (2004) 2018;91:157–168. PubMed PMC

Abdullahi IN, Anka AU, Ghamba PE, et al. . Need for preventive and control measures for Lassa fever through the One Health strategic approach. Proc Singapore Healthc 2020;29:190–194.

Gibb R, Moses LM, Redding DW, et al. . Understanding the cryptic nature of Lassa fever in West Africa. Pathog Glob Health 2017;111:276–288. PubMed PMC

Shaffer JG, Grant DS, Schieffelin JS, et al. . Viral Hemorrhagic Fever Consortium. Lassa fever in post-conflict sierra leone. PLoS Negl Trop Dis 2014;8:e2748. PubMed PMC

Lalis A, Leblois R, Lecompte E, et al. . The impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West Africa. PLoS ONE 2012;7:e37068. PubMed PMC

Gowen BB, Bray M. Progress in the experimental therapy of severe arenaviral infections. Future Microbiol 2011;6:1429–1441. PubMed PMC

Alli A, Ortiz JF, Fabara SP, et al. . Management of Lassa fever: a current update. Cureus 2021;13:e14797. PubMed PMC

Wang P, Liu Y, Zhang G, et al. . Screening and identification of Lassa virus entry inhibitors from an FDA-approved drug library. J Virol 2018;92:e00954-18. PubMed PMC

Hickman MR, Saunders DL, Bigger CA, et al. . The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections. PLoS Negl Trop Dis 2022;16:e0010220. PubMed PMC

Liu Y, Guo J, Cao J, et al. . Screening of botanical drugs against Lassa virus entry. J Virol 2021;95:e02429-20. PubMed PMC

Cashman KA, Wilkinson ER, Shaia CI, et al. . DNA vaccine delivered by dermal electroporation fully protects Cynomolgus macaques against Lassa fever. Hum Vaccin Immunother 2017;13:2902–2911. PubMed PMC

Fischer RJ, Purushotham JN, van Doremalen N, et al. . ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge. NPJ Vaccines 2021;6:32. PubMed PMC

Mateo M, Reynard S, Journeaux A, et al. . A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains. Sci Transl Med 2021;13:eabf6348. PubMed

Salvato MS, Domi A, Guzmán-Cardozo C, et al. . A single dose of modified vaccinia ankara expressing Lassa virus-like particles protects mice from lethal intra-cerebral virus challenge. Pathogens 2019;8:133. PubMed PMC

Johnson DM, Cubitt B, Pfeffer TL, et al. . Lassa virus vaccine candidate ML29 generates truncated viral RNAs which contribute to interfering activity and attenuation. Viruses 2021;13:214. PubMed PMC

Fisher-Hoch SP, Hutwagner L, Brown B, et al. . Effective vaccine for Lassa fever. J Virol 2000;74:6777–6783. PubMed PMC

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...